Real-World Tirzepatide Therapy in Post-Bariatric Weight Regain and Preoperative Obesity Patients

NCT07382180 · clinicaltrials.gov ↗

COMPLETED

Status

254

Enrollment

OTHER

Sponsor class

Conditions

Obesity & Overweight
Weight Regain
Obesity, Morbid

Interventions

DRUG: Tirzepatide is administered as part of routine clinical care for obesity management, according to standard prescribing practices. Dosing and treatment duration are determined by the treating physician

Sponsor

Azienda Sanitaria Locale Napoli 2 Nord